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Abstract
Background:  The marine cyanobacterium Lyngbya majuscula is a prolific producer of bioactive secondary
metabolites. Although biosynthetic gene clusters encoding several of these compounds have been identified, little
is known about how these clusters of genes are transcribed or regulated, and techniques targeting genetic
manipulation in Lyngbya strains have not yet been developed. We conducted transcriptional analyses of the
jamaicamide gene cluster from a Jamaican strain of Lyngbya majuscula, and isolated proteins that could be involved
in jamaicamide regulation.
Results:  An unusually long untranslated leader region of approximately 840 bp is located between the
jamaicamide transcription start site (TSS) and gene cluster start codon. All of the intergenic regions between the
pathway ORFs were transcribed into RNA in RT-PCR experiments; however, a promoter prediction program
indicated the possible presence of promoters in multiple intergenic regions. Because the functionality of these
promoters could not be verified in vivo, we used a reporter gene assay in E. coli to show that several of these
intergenic regions, as well as the primary promoter preceding the TSS, are capable of driving β-galactosidase
production. A protein pulldown assay was also used to isolate proteins that may regulate the jamaicamide
pathway. Pulldown experiments using the intergenic region upstream of jamA as a DNA probe isolated two
proteins that were identified by LC-MS/MS. By BLAST analysis, one of these had close sequence identity to a
regulatory protein in another cyanobacterial species. Protein comparisons suggest a possible correlation between
secondary metabolism regulation and light dependent complementary chromatic adaptation. Electromobility shift
assays were used to evaluate binding of the recombinant proteins to the jamaicamide promoter region.
Conclusion: Insights into natural product regulation in cyanobacteria are of significant value to drug discovery
and biotechnology. To our knowledge, this is the first attempt to characterize the transcription and regulation of
secondary metabolism in a marine cyanobacterium. If jamaicamide is light regulated, this mechanism would be
similar to other cyanobacterial natural product gene clusters such as microcystin LR. These findings could aid in
understanding and potentially assisting the management of toxin production by Lyngbya in the environment.
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Background
Over the past 30 years, the search for bioactive secondary
metabolites (natural products) from marine organisms
has yielded a wealth of new molecules (estimated at
~17,000) with many fundamentally new chemotypes and
extraordinary potential for biomedical research and appli-
cations [[1], and previous references therein]. Marine
cyanobacteria continue to be among the most fruitful
sources of marine natural products, with nearly 700 com-
pounds described [2,3]. The filamentous marine cyano-
bacterium  Lyngbya majuscula (Gomont) is of particular
importance, as approximately 35% of all cyanobacterial
bioactive compounds have been reported from the genus
Lyngbya, with 76% of these coming from L. majuscula [3].
More recently, compound isolation and structure elucida-
tion from L. majuscula has been complemented with the
characterization of biosynthetic gene clusters that encode
a number of these compounds. The gene clusters for sev-
eral potent anticancer and neurotoxic agents such as
curacin A, barbamide, and the jamaicamides have pro-
vided new insight into the biosynthetic strategies and
logic used by this organism for compound production, as
well as unique enzymes involved in unprecedented
molecular tailoring reactions [4-7].
Despite considerable interest in pursuing cyanobacterial
lead compounds as potential drug candidates, an ade-
quate supply of these compounds for clinical research is
often impossible to obtain without impractically large
scale field collections or sophisticated and expensive syn-
thetic methods [8,9]. With some notable examples [10-
13] it has been difficult to induce microbial gene clusters
to produce their natural products in heterologous hosts,
and thus this technology is not currently predictable [14].
Equally problematic, filamentous marine cyanobacteria
such as Lyngbya grow slowly in laboratory culture, with
doubling times in some cases of about 18 days [15].
One avenue for increasing compound production from
marine cyanobacteria could be to take advantage of regu-
latory elements associated with a biosynthetic gene cluster
of interest. Although genetic controls of several primary
metabolic functions in cyanobacteria including circadian
rhythms [16], heterocyst development [17], and nutrient
uptake [18] have been described, information regarding
transcriptional regulation of cyanobacterial secondary
metabolites is currently limited to freshwater toxins such
as the microcystins. The microcystins are potent hepato-
toxins synthesized by several freshwater cyanobacteria of
worldwide occurrence [19] and are generated via a mixed
polyketide synthase/non-ribosomal peptide synthetase
(PKS/NRPS) gene cluster [20]. Expression of the microcys-
tin gene cluster is positively correlated with increased light
intensity and red light in particular [21]. Moreover, the
gene cluster has different transcription start sites depend-
ing on light levels [22]. Other environmental factors have
been evaluated for their effects on microcystin produc-
tion, and increasing evidence suggests that iron may be
important. Transcription of genes from the microcystin
gene cluster increases with iron starvation [23], and in the
presence of iron, a ferric uptake regulator (Fur) protein
appears to bind to the microcystin bidirectional promoter
and may decrease microcystin production [24]. Because it
complexes with iron and other metals [25] microcystin
may therefore function as a siderophore. Alternatively,
microcystin has been proposed to serve in intraspecies
communication, where release of the compound is inter-
preted as cell death by other Microcystis sp. and causes
increased microcystin production to enhance localized
toxicity [26].
As with microcystin, many of the toxins found in L. majus-
cula are also produced by gene clusters comprised of PKS/
NRPS architecture. PKS/NRPS gene clusters in other bacte-
ria have been found to include imbedded regulatory pro-
teins, such as the Streptomyces  Antibiotic  Regulatory
Proteins (SARPs) found within the confines of several
antibiotic pathways in Streptomyces [27]. However, cyano-
bacterial natural product gene clusters identified to date
do not contain any apparent associated regulatory pro-
teins.
Insight into the mechanisms used by L. majuscula in the
transcription of secondary metabolite gene clusters could
be of significant value in enhancing the overproduction of
potential drug leads in laboratory culture. Increased com-
pound yield would reduce the need and environmental
impact of repeated large scale field collections or the time
and expense of chemical synthesis. Additionally, because
the secondary metabolite biosynthetic gene clusters iden-
tified thus far from L. majuscula have been from different
strains of the same species, transcription of each pathway
could be under similar mechanisms of regulation.
This paper provides an analysis of transcriptional regula-
tory elements associated with the jamaicamide gene clus-
ter from Lyngbya majuscula, and to our knowledge is the
first such effort for a secondary metabolite gene cluster
from a marine cyanobacterium. The jamaicamides are
mixed PKS/NRPS neurotoxins that exhibit sodium chan-
nel blocking activity and fish toxicity. The molecules con-
tain unusual structural features including a vinyl chloride
and alkynyl bromide [6]. The gene cluster encoding jamai-
camide biosynthesis is 57 kbp in length, and is composed
of 17 ORFs that encode for proteins ranging in length
from 80 to 3936 amino acids. Intergenic regions between
5 and 442 bp are located between all but two of the ORFs,
and a region of approximately 1700 bp exists between the
first jamaicamide ORF (jamA, a hexanoyl ACP synthetase)
and the closest upstream (5') ORF outside of the cluster (aBMC Microbiology 2009, 9:247 http://www.biomedcentral.com/1471-2180/9/247
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putative transposase). In this study, we used RT-PCR to
locate the transcriptional start site (TSS) of the jamaica-
mide gene cluster. Because it is not yet possible to perform
genetics in filamentous marine cyanobacteria such as Lyn-
gbya, we used a reporter gene assay to identify several pos-
sible internal pathway promoters. We also isolated at least
one possible regulatory protein using pulldown experi-
ments that is able to bind to the region upstream of the
transcription start site in gel shift assays. Bioinformatic
analyses conducted with the protein sequence suggest a
correlation between secondary metabolite production
and complementary chromatic adaptation (CCA) in
cyanobacteria.
Results
RT-PCR using L. majuscula RNA to search for the 
transcriptional start site (TSS) and promoter regions in the 
jamaicamide pathway
The initial characterization of the jamaicamide gene clus-
ter [6] described that the first 16 ORFs of the gene cluster
(jamA-jamP) are all transcribed in the forward direction,
while the last ORF (jamQ, a putative condensation
domain thought to be involved in the cyclization of the
pyrrolinone ring of the molecule) is transcribed in the
reverse direction (Figure 1). In order to determine the
location of the transcriptional start site (TSS) of the gene
cluster, RNA was isolated from the jamaicamide produc-
ing strain of Lyngbya majuscula (JHB). First strand cDNA
was synthesized using reverse transcriptase and a reverse
primer designed as a complement to the 5' end of the
jamA  gene (Additional file 1: Table S1). Initial experi-
ments creating second strand cDNA using the first strand
cDNA as template found that an unusually long untrans-
lated leader region of at least 500 bp preceded jamA. A
primer extension experiment was conducted in which sec-
ond strand cDNA was amplified in 50 bp increments
beyond this 500 bp location. The experiment indicated
that transcription of RNA began between 850 bp and 902
bp upstream of the jamA ORF start site (Figure 2). Using
comparisons to consensus promoter and transcription
start regions in E. coli [28-30], a putative promoter was
identified which, relative to a probable TSS (844 bp
Structures of the jamaicamides and the jamaicamide biosynthetic gene cluster [6] Figure 1
Structures of the jamaicamides and the jamaicamide biosynthetic gene cluster [6]. Genes associated with the path-
way are represented by black arrows, and genes flanking the pathway are represented in gray. Elevated arrows above the 
upstream regions of selected open reading frames indicate where promoter activity was detected using the β-galactosidase 
reporter assay. The region upstream of jamQ did not have any detectable promoter activity in the assay.BMC Microbiology 2009, 9:247 http://www.biomedcentral.com/1471-2180/9/247
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upstream of jamA), included conserved hexamer RNA
polymerase (RNAP) binding sites at -35 and -10 bp, a con-
served extended -10 TGn region upstream of the -10 box,
and an optimal DNA length between the hexamers (17
bp) (Figure 3).
We also evaluated whether the jamaicamide gene cluster
contained non-transcribed intergenic regions between
ORFs that could indicate the presence of breaks in the
transcripts. Primers designed for those intergenic regions
in the pathway 20 bp in size or larger (all but 2 intergenic
regions) were used for synthesizing and amplifying cDNA
to determine whether they were transcribed. All of the
intergenic regions in the jamaicamide pathway tested
were amplified into second strand cDNA, including the
intergenic region between jamP and jamQ. Intergenic
regions between the two ORFs downstream of jamQ
(putative transposases) were also transcribed. These
results indicated that the majority of the jamaicamide
gene cluster is composed of the operon jamABCDEFGHI-
JKLMNOP. Because no apparent breaks in transcription
occurred between jamQ and at least the two neighboring
downstream transposases (ORF5 and ORF6) and a hypo-
thetical protein (ORF7), one contiguous transcript may
encode the translation of all of these proteins. Transcrip-
tion of the intergenic region between jamP and jamQ
indicated that a transcript including jamP must extend at
least into the complementary strand of jamQ before ter-
mination, although transcription in the opposite direc-
tion would be necessary to generate jamQ mRNA.
Use of promoter prediction and  -galactosidase reporter 
gene assays to search for promoter activity
The large size (approximately 55 kbp) of the main jamai-
camide operon (jamA-P) suggested that multiple promot-
ers would likely be needed for efficient jamaicamide
transcription. Because transcripts were found for each of
the intergenic regions between the ORFs, these promoters
may function intermittently and could be subject to pro-
moter occlusion [22]. A software prediction program
(BPROM, http://www.softberry.com) was used to predict
whether the intergenic regions from the jamaicamide
pathway contained conserved promoter binding regions.
Several of these regions were predicted to contain at least
one potential pair of -35 and -10 binding sites (Table 1).
Because transformation methods into L. majuscula have
not yet been developed, we used a reporter gene assay in
E. coli to determine whether any of these upstream (up-)
regions could function as promoters. Each region pre-
dicted to contain a promoter (upjamA, upjamB, upjamC,
upjamD, upjamG, upjamI, upjamN, and upjamQ), as well
as the promoter upstream of the jamaicamide TSS, was
amplified with specific primers from fosmids containing
different portions of the jamaicamide biosynthetic path-
way ([6]; Additional file 1: Table S1). Each of these
regions were individually ligated into the pBLUE TOPO
vector (Invitrogen) and transformed into TOP-10 E. coli.
The resulting constructs were evaluated for relative pro-
moter activity using the β-galactosidase reporter gene
assay (Invitrogen), standardized against total soluble pro-
tein content measured by BCA assay (Pierce). For upjamA,
two regions were evaluated, including the region pre-
dicted to contain the initial promoter, as well as immedi-
ately upstream of the jamA  gene (a region with high
activity in preliminary assays). The arabinose promoter
from E. coli was amplified from the pBAD vector (Invitro-
gen) and ligated into the pBLUE vector as a positive con-
trol, while a 49 bp segment of a jamaicamide pathway
gene (jamG) ligated into pBLUE vector was used as a neg-
ative control.
Several of the tested intergenic regions exhibited signifi-
cantly stronger promoter activity than the positive con-
trol, including the promoter identified from the primer
extension experiment (upjamA-902 - -832 bp), as well as
Transcription start site (TSS) primer extension experiment  using first strand cDNA upstream of jamA (top) or jam fos- mid (bottom) as PCR templates Figure 2
Transcription start site (TSS) primer extension 
experiment using first strand cDNA upstream of 
jamA (top) or jam fosmid (bottom) as PCR tem-
plates. The upstream region sizes (e.g., 600-0, 650-0) are 
indicated above each lane.BMC Microbiology 2009, 9:247 http://www.biomedcentral.com/1471-2180/9/247
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upjamB, upjamD, and upjamI (Figure 4). The intergenic
regions upjamG and upjamN both had some promoter
activity, although lower than the positive control. The
region upstream of jamQ did not have any detectable pro-
moter activity in the assay, which suggested that the pro-
moter for this transcript may be located upstream of an
adjacent ORF.
To more precisely localize the promoter regions upstream
of two of these genes, a series of additional assays were
conducted using truncated regions of upjamA (immedi-
ately upstream of the jamA gene) and upjamI. For upjamA,
promoter activity was comparable relative to the positive
control when testing longer upstream fragments (-500 - 0
and -200 - 0 bp; Figure 5). However, when small frag-
ments closer to the jamA ORF start site were used, the pro-
moter activity increased significantly, with maximal
activity observed for the fragment -76 - 0 bp upstream of
jamA. The promoter in the -76 - 0 region appeared to
require the sequence fragment -38 - 0, as another con-
struct containing the region upjamA-96 - -38 did not have
any promoter activity. The entire 269 bp upjamI upstream
region also displayed strong promoter activity relative to
the positive control. Promoter activity was lost using frag-
ments encompassing -269 - -68 bp, but restored using the
fragment -67 - 0 bp (Figure 5). Inspection of the sequences
included in these active, truncated regions of upjamA and
upjamI led to the identification of possible conserved pro-
moter elements in close proximity to the ORF start sites
for both genes (Table 1).
To quantitatively determine the promoter activities of the
DNA fragments, a series of β-galactosidase assays incorpo-
rating a serial dilution of E. coli soluble protein lysate was
Location of identified promoter regions and transcription start site (TSS) upstream of jamA Figure 3
Location of identified promoter regions and transcription start site (TSS) upstream of jamA. The consensus -35 
and -10 boxes of each region are underlined. The conserved extended -10 TGn box of the primary pathway promoter is dou-
ble underlined. The putative TSS is noted at +1, and was chosen based on similarities to the consensus E. coli TSS nucleotide 
region [29]. The first four codons of the jamA gene are noted at the end of the sequence.BMC Microbiology 2009, 9:247 http://www.biomedcentral.com/1471-2180/9/247
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also used in order to avoid saturation problems in color
development (Figure 6). These data were used to calculate
β-galactosidase activity in terms of nmol ONPG hydro-
lyzed min-1 mg soluble protein-1 for each of the upstream
fragments with any detectable promoter activity. The
strongest promoter was the section upstream of the jamai-
camide TSS (-902 - -832 upstream of jamA), with an aver-
age of approximately 950 nmol ONPG hydrolyzed min-1
mg soluble protein-1. The promoter immediately
upstream of jamA (-76 - 0) and those upstream of jamB,
jamD, and jamI  yielded lower values, with upjamA,
upjamB and upjamI between 500-700 nmol ONPG hydro-
lyzed min-1 mg soluble protein-1, and upjamD at approxi-
mately 265 nmol ONPG hydrolyzed min-1 mg soluble
protein-1. Reduced activity was found for promoters
upstream of jamC, jamG, and jamN, with values ranging
from approximately 75 to 150 nmol ONPG hydrolyzed
min-1 mg soluble protein-1. The arabinose promoter posi-
tive control construct yielded an average value of 170
nmol ONPG hydrolyzed min-1 mg soluble protein-1.
Isolation and characterization of possible transcription 
factors from a pulldown assay
To determine whether jamaicamide regulatory proteins
are encoded in the L. majuscula JHB genome, we per-
formed DNA - protein "pulldown" experiments to isolate
proteins with affinity to the upstream region of jamA. A
Table 1: Predicted -35 and -10 promoter regions (bold) and transcription start sites (TSS; nucleotides in bold italics at the end of each 
sequence) for intergenic regions in the jamaicamide gene cluster (accession #AY522504). 
Upstream region of gene Predicted TSS location 
(bp)
ORF start (bp)
upjamA 6626 6630 CTGACTTTCCACGACATGGGACTGATGGGAAATGTATATTTAT
TTGA
upjamB 8464 8591 GTGGGTTGATTTGATCAAGTTTGATGATATAATTTGATTTA
upjamB 8501 8591 TTTAATTTACAGGGATACCGCCAATTCGGTAACCTGGAAAA
upjamC 9614 9718 AAAACTTGTCAACCTGAACAAGATCCTGAACAAAATATTGTTG
upjamD 10433 10463 ACAGTTTGATGGTGCCGCTATTTTGAAGTTGGAAAATTTTTTA
upjamG 18145 18222 ATTTGTTGTTTGGGAATCGGGAATTGGTATTAGTAGTGGAA
upjamI 20776 20982 CGGAATTCAAAATTCAAAATTCAAAATGCTTATGGATTATGGA
GTAAA
upjamI 20989 20982 CCAGGTTGACAAACCATTGATAAAGCTATAGTATGTATTA
upjamN 51787 51811 TGGAGTATAAAAAACAGAGCCTGGTGATAGTTAATTAA
upjamQ 63710a 63646a GAACTTTGAATCCTCTATTTTGATTAAATTTGGAGA
a: Numbers correspond to bp in complementary 3' - 5' direction.
Bold -35 and -10 binding regions were predicted using BPROM (softberry.com) in comparison to the E. coli σ70 consensus -35 (TTGACA) and -10 
(TATAAT) promoter regions.  If upstream regions had more than one predicted promoter region, the region receiving the highest predicted score 
is provided (with the exception of upjamB, which had two high scoring regions, and upjamI, in which both predicted promoters were tested in the 
β-galactosidase assay). Each upstream region listed in the first column had activity in the reporter assay, except those not shown in bold text.  The 
italic ATG in the second upjamI predicted promoter region indicates the jamI start codon.  TSS nucleotides were predicted to be A or G based on 
comparisons to the most common TSS nucleotides in E. coli[29].
Relative activity of the primary promoter upstream of jamA  and predicted promoters in jamaicamide intergenic regions in  the β-galactosidase reporter assay Figure 4
Relative activity of the primary promoter upstream 
of jamA and predicted promoters in jamaicamide 
intergenic regions in the β-galactosidase reporter 
assay. Standard error is represented by error bars.
Activity of truncated upjamA and upjamI regions in the β- galactosidase assay Figure 5
Activity of truncated upjamA and upjamI regions in 
the β-galactosidase assay. Trimmed regions are repre-
sented by blue shaded figures with associated base pair num-
bers. Red arrows indicate the start codon of the downstream 
ORF (jamA or jamI). Relative activity was calculated on same 
scale as Figure 4. Standard error is represented by error 
bars.BMC Microbiology 2009, 9:247 http://www.biomedcentral.com/1471-2180/9/247
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biotinylated, DNA probe extending from 1000 bp
upstream of jamA to 20 bp into the jamA gene (encom-
passing both the putative promoter region and entire
untranslated leader region; primers in Additional file 1:
Table S1) was used to label streptavidin coated magnetic
Dynabeads (Invitrogen), which were then incubated with
a soluble protein lysate from L. majuscula JHB. A series of
wash steps were first conducted to remove proteins non-
specifically bound, followed by elution of those proteins
specifically bound to the probe. This elution was visual-
ized using SDS-PAGE and revealed at least two bands of
approximately 30-45 kDa in size (Figure 7). The protein
bands from the gel, as well as crude fractions eluted from
the magnetic beads in repeated experiments, were ana-
lyzed with LC-MS/MS.
The fragmented peptides generated from the LC-MS/MS
analysis of the gel bands were used to query the unfin-
ished Lyngbya majuscula 3L genome (a strain from Curaçao
that produces several natural products, including bar-
bamide and curacin A) using the MS/MS post-processing
program InSpecT [31]. By this approach, two proteins
were identified with high confidence from "band 2" (Fig-
ure 7), which had a global distribution (N-terminal to C-
terminal) among the identified peptides: (i) All4300 pro-
tein (39.2% coverage and a molecular weight of 32 kDa),
and (ii) hypothetical protein (35.9% coverage and a
molecular weight of 33 kDa). Manual annotation of the
most abundant peptide identified within the primary
sequence of All4300 demonstrated the b and y ion series
fell within a mass error of 5-400 ppm. Furthermore, the b
and y-ion series for this peptide showed 22/30 possible
fragmentations covered with several contingent ion series.
The ion series for the hypothetical protein showed similar
results to the All4300 protein. Results from the LC-MS/MS
of the PAGE gel "band 1" (Figure 7) were inconclusive.
Separate analyses of the elution fractions identified with
high confidence the same All4300 and hypothetical pro-
tein from band 2, as well as a number of putative proteins
in the 3L genome such as a peptidase (~45 kDa) and an
AP endonuclease (~30 kDa). Several pigment related pro-
teins were also identified that were not visually apparent
by SDS-PAGE (smaller than the two main bands indicated
on Figure 7), including C-phycoerythrin class 1 subunit
alpha (~19 kDa), allophycocyanin alpha subunit (~17
kDa), and photosystem I (PsaD) (~16 kDa).
BLAST analyses of the All4300 and the hypothetical pro-
tein (referred to subsequently as protein 5335 and protein
7968, respectively, from the L. majuscula 3L genome;
annotations in progress) both yielded a number of hypo-
thetical protein matches in other cyanobacteria including
Anabaena variabilis, Microcoleus chthonoplastes, Nostoc punc-
tiforme, and Trichodesmium erythraeum (JHB protein BLAST
hits in Table 2; see below). Interestingly, both proteins
also matched (although significantly better for 7968) with
the protein RcaD, an activator protein from the cyanobac-
terium  Calothrix  (=  Fremyella diplosiphon or  Tolypothrix)
known to regulate complementary chromatic adaptation
[32-35]. Complementary chromatic adaptation (CCA) is a
phenomenon exhibited by many cyanobacteria in
response to changes in light wavelength and intensity.
CCA allows cyanobacteria to alter pigment levels so as to
optimize their capacity for photosynthesis, and usually
involves variation between green and red phenotypes
[36]. RcaD is a protein that binds to the promoter for phy-
cocyanin 2 (cpc2) and alters the expression of several red
light operons in the acclimation phase of CCA [34,35].
Another protein, RcaG, is located downstream of RcaD
and has been identified as a putative ATPase. RcaG may
facilitate binding of RcaD to DNA, and could require
Specific activity of the strongest promoters in the β-galactos- idase assay Figure 6
Specific activity of the strongest promoters in the β-
galactosidase assay. Base pair number relative to gene 
ORF start site is provided when necessary. Standard error is 
represented by error bars.
Results from JHB soluble protein pulldown experiment Figure 7
Results from JHB soluble protein pulldown experi-
ment. From left to right: Ladder, JHB soluble protein lysate, 
wash fractions (W1 - 5) and elution (E) for incubations with 
the 1020 bp probe (labeled JHB) or without probe (labeled -
control). Note the presence of two bands eluted from the 
beads containing the probe, indicating successful binding of 
possible regulatory proteins to the upstream region of jamA.BMC Microbiology 2009, 9:247 http://www.biomedcentral.com/1471-2180/9/247
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phosphorylation to complete this task [34]. Bioinformatic
analysis of the L. majuscula 3L genome revealed that the
proteins immediately downstream of 5335 and 7968
both resulted in BLAST hits with RcaG, although as with
RcaD, the protein neighboring 7968 (7969) had much
stronger sequence identity than the neighboring protein
to 5335 (5336).
Primers were designed from each of the gene sequences
for the two proteins identified above using the L. majus-
cula 3L unfinished genome, and were successful in ampli-
fying homologous gene sequences from L. majuscula JHB
genomic DNA. The JHB homolog to 5335 encodes for a
protein that differs from the 3L protein by only one amino
acid (99.6% identical), while the 7968 homolog in JHB
encodes for a protein 89.5% identical to the 7968 protein
in 3L. Alignments of each JHB protein with their nearest
respective BLAST hits (alignment of protein 7968 shown
in Additional file 2: Figure S1) indicated several conserved
sequence regions, with the highest level of conservation
found toward the C terminal end of the proteins (a region
in the RcaD protein thought to be involved in DNA bind-
ing) [34].
Recombinant expression of identified proteins and 
Electromobility Shift Assays (EMSAs)
The sequences encoding the 5335 and 7968 proteins in
JHB were used in creating constructs for recombinant
expression in E. coli (Figure 8). After expression and puri-
fication of each protein, both were used in Electromobil-
ity Shift Assays (EMSAs). In these assays, protein and a
fragment of DNA amplified from a region that included
both the sequence of the primary jamaicamide promoter
and the region upstream from the original probe (1000 -
832 bp upstream of jamA) were incubated and visualized
on native PAGE gels. Recombinant 7968 was found to
bind this putative transcription factor binding region
upstream of jamA after His tag removal with thrombin
cleavage (Figure 9a), although promiscuous binding was
also observed with other control DNA fragments (data not
shown). A serial titration of 7968 with the N-terminal His
tag still attached showed increased DNA binding with
larger amounts of protein (Figure 9b). Recombinant pro-
tein 5335 was expressed and purified with a GST-tag on
the N-terminus of the protein. However, attempts to
remove the GST tag were unsuccessful, and thus we
assayed protein 5335 with the GST tag still attached (Fig-
ure 8c). This version of 5335 did not bind to the upjamA-
Table 2: BLAST results with Lyngbya majuscula JHB proteins 5335 and 7968.
5335 (279 aa)
Best BLAST hit BLAST organism Size (aa) identity similarity e value accession #
hypothetical protein Nostoc punctiforme PCC 73102 217 56 70 8.00E-62 YP_001867255
hypothetical protein Microcoleus chthonoplastes PCC 7420 245 56 71 2.00E-59 ZP_05025825
hypothetical protein all4300 Nostoc sp. PCC 7120 227 49 68 4.00E-54 NP_488340
hypothetical protein Anabaena variabilis ATCC 29413 221 49 65 1.00E-51 YP_321771
hypothetical protein Lyngbya sp. PCC 8106 224 47 64 9.00E-47 ZP_01623947
hypothetical protein Lyngbya sp. PCC 8106 156 33 56 2.00E-11 ZP_01621638
hypothetical protein Nodularia spumigena CCY9414 100 41 61 3.00E-11 ZP_01628571
hypothetical protein Arthrospira maxima CS-328 131 32 60 1.00E-08 ZP_03271683
RcaD protein Tolypothrix sp. PCC 7601 285 22 48 0.2 CAC39267
7968 (304 aa)
Best BLAST hit BLAST organism Size (aa) identity similarity e value accession #
hypothetical protein Cyanothece sp. PCC 7424 274 49 69 2.00E-68 YP_002380360
RcaD protein Tolypothrix sp. PCC 7601 285 43 63 3.00E-54 CAC39267
hypothetical protein Trichodesmium erythraeum IMS101 272 40 59 3.00E-52 YP_720119
hypothetical protein Nodularia spumigena CCY9414 280 44 62 1.00E-50 ZP_01631082
hypothetical protein Microcoleus chthonoplastes PCC 7420 287 41 62 7.00E-50 ZP_05025219
hypothetical protein Synechococcus sp. PCC 7335 199 33 57 3.00E-22 ZP_05035072
Recombinant expression of JHB proteins Figure 8
Recombinant expression of JHB proteins. A: Protein 
expression from L. majuscula JHB 7968 (His+protein: ~37 
kDa). Arrow indicates eluted protein. B: Protein 7968 after 
thrombin His tag cleavage and concentration. Arrow indi-
cates cleaved protein. C: Protein expression from L. majus-
cula JHB 5335 GST fusion vector (GST+protein: ~60 kDa). 
Arrow indicates eluted GST+5335 protein.BMC Microbiology 2009, 9:247 http://www.biomedcentral.com/1471-2180/9/247
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1000 - -832 bp region (Figure 9a), even with elevated pro-
tein concentrations (Additional file 3: Figure S2).
Discussion
In this study, we explored the transcriptional machinery
associated with the jamaicamide biosynthetic gene cluster
in Lyngbya majuscula. The jamaicamide cluster was chosen
because it possesses a number of features commonly seen
in other secondary metabolites isolated from marine
cyanobacteria [3]. The jamaicamides are produced by the
most prolific cyanobacterial natural product producer yet
known (L. majuscula), are bioactive (ichthyotoxic, neuro-
toxic), are composed of mixed PKS/NRPS derived subu-
nits, and contain unusual structural features such as a
vinyl chloride and alkynyl bromide rarely seen in natural
products from other organisms.
The first description of the jamaicamides [6] demon-
strated that the cluster is composed of 17 ORFs, with 16
transcribed in the same direction. The cluster is flanked on
the 5' and the 3' ends by transposases and hypothetical
proteins. From the results of our RT-PCR experiments, it
appears that the gene cluster is preceded by an unusually
long untranslated leader region (at least 844 bp), one that
may be unprecedented in size for a secondary metabolite
gene cluster. The function of having such a long region
between the TSS and the start codon of jamA is unclear at
this time, but may be important for overall regulation of
the pathway. In Synechococcus PCC 7942, the psBAII and
psBAIII genes encoding the photosystem II reaction center
D1 protein have cis regulatory elements in addition to
basal promoters. Contained in the untranslated leader
region downstream of the psB TSS are light responsive ele-
ments that were found to be responsible for increased
expression of the genes under high light conditions [37].
In the jamaicamide pathway, the fact that another region
of DNA immediately upstream of jamA can function as a
strong promoter indicates that although transcription
may initiate well before the ORF start site, there could be
a supplemental means of boosting transcription closer to
the first protein in the cluster.
The amplification of second strand cDNA from JHB RNA
corresponding to all of the intergenic regions between the
jamaicamide ORFs tested indicated that the pathway is
transcribed in at least two pieces. The first, jamABCDEF-
GHIJKLMNOP, is sufficiently large (~55 kb) to assume
that multiple transcripts could be needed to process this
portion of the gene cluster. A similar situation was found
with the microcystin gene cluster [22], in which all of the
intergenic regions of the pathway aside from the bidirec-
tional promoter were transcribed, and RACE experiments
with several of these regions detected variations in inter-
genic TSS locations. As with microcystin, the jamaicamide
pathway could contain internal promoters which, while
not representing true breaks in the transcription of the
pathway, can function independently if not overwritten
by RNAP acting from an upstream promoter (promoter
occlusion; [38]). Indeed, several of these regions were able
to function as promoters in a reporter assay (see below).
A second transcript in the direction complementary to the
large transcript in the jamaicamide pathway is probably
needed to include jamQ, a gene encoding a condensation
like protein that is likely involved with the creation of the
pyrrolinone ring of the molecule. According to our RT-
PCR experiments, the regions between jamQ and the three
genes closest upstream (ORF5  and  ORF6, both trans-
posases, and ORF7, a hypothetical protein), are all tran-
scribed. In addition, the upstream region of jamQ does
not appear to serve as a strong promoter in β-galactosidase
reporter assays (see below), despite the presence of possi-
ble conserved promoter domains (Table 1). From these
data, it appears that jamQ could be part of a larger tran-
script including these transposases. A larger intergenic
region (approximately 1070 bp) lies upstream of ORF7,
which could contain the TSS and a promoter for this tran-
script. The reason for including at least one transposase in
the jamQ transcript is unclear, but this may be a way of
ensuring transposable elements have remained associated
with the cluster so as to facilitate horizontal gene transfer
and pathway evolution. The hectochlorin biosynthetic
gene cluster from L. majuscula JHB [39] contains a trans-
Electromobility shift assays Figure 9
Electromobility shift assays. A) EMSA gel shift assay with 
DNA region -1000 - -832 bp upstream of jamA. DNA [270 
fmol (= 30 ng)] was assayed with (from left to right) no pro-
tein, 7.3 pmol of 7968, 8.4 pmol of GST+5335, or 31 pmol of 
HctEIVA. Arrow indicates DNA + protein shift for 7968. B) 
Serial titration experiment with 45 fmol (= 5 ng) of the same 
DNA region with (from left to right) no protein, 6.8 pmol, 
13.7 pmol, 27.3 pmol, or 54.8 pmol His+7968. Arrow indi-
cates DNA + protein shift.BMC Microbiology 2009, 9:247 http://www.biomedcentral.com/1471-2180/9/247
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posase (hctC) located between two of the initial genes
(hctB and hctD) in the pathway, which is also thought to
contribute to the plasticity of the cluster.
Biosynthetic investigations using Lyngbya majuscula strains
have been highly successful in identifying secondary
metabolite gene clusters, in part because L. majuscula read-
ily incorporates isotopically labeled precursors in feeding
studies [5,6]. However, further experimentation by way of
gene knockout or overexpression in L. majuscula is not yet
possible because a viable means of genetic transformation
has not been developed. Due to this limitation, we used
genetic constructs in E. coli to determine whether the pro-
moters identified in this study, including the primary
pathway promoter upstream of the TSS and those pre-
dicted in intergenic regions, were functional. Although
some differences exist in the structure of RNAP between
the two bacteria [40], promoter structures in cyanobacte-
ria are often compared to consensus sequences in E. coli
[22,41]. Furthermore, a strong E. coli promoter has been
shown to function in the cyanobacterium Synechococcus
[37] and the psb2 promoter from Microcystis can be used
in E. coli to drive β-galactosidase production [42]. The
reporter assay proved effective in verifying the promoter
identified upstream of the jamaicamide pathway TSS, as
well as several internal promoters located at various
regions throughout the gene cluster (Figures 4, 5 and 6).
Previous studies with β-galactosidase reporter assays have
been useful in demonstrating how enhancer elements
within untranslated leader regions and intergenic promot-
ers are important in driving transcription [37,43]. The
strongest promoter in the assay was that identified
upstream of the jamA TSS, but several other promoters
were either equal to or greater in strength than the positive
control in the assay. One of the regions predicted to con-
tain a strong promoter (upjamI) is located in front of a
large set of ORFs. The ORF jamI, encoding an enoyl-CoA
hydratase/isomerase, forms a di-domain with jamJ, which
encodes for an enoyl reductase and a large PKS [6]. In
addition, the subsequent ORFs in the pathway (jamK - M)
are separated by small intergenic regions and do not
appear to contain promoters. If jamI - M form one contig-
uous transcript (~30 kb), a promoter in front of jamI
could be needed for efficient transcription. The identifica-
tion of functional promoters in several other intergenic
regions suggests that they could also be used to boost tran-
scription beyond the capacity of the initial promoter
located before the TSS upstream of jamA.
One intriguing finding from using truncated intergenic
regions in the β-galactosidase assay was the detection of
strong activity immediately upstream of jamA (-76 - 0)
and jamI (-67 - 0) (Figure 5). An additional promoter was
predicted in a region of upjamI  (-269 - -203) farther
upstream in the 5' direction (Table 1), but this region was
not active when used in truncated form (Figure 5). If these
active regions upstream of jamA (-76 - 0) and jamI (-67 -
0) are able to act as internal promoters to supplement
overall transcription of the jamaicamide pathway, their
close proximity to jamA and jamI may compromise the
ability of transcripts initiating at these positions to subse-
quently allow for proper translation of the JamA and JamI
proteins (although transcription could take place nor-
mally downstream of each location). This could occur as
a result of insufficient room for a ribosome binding site,
although translation of mRNA in cyanobacteria may not
require the use of Shine-Dalgarno sequences [44] and
some evidence exists for translation of leaderless mRNA in
bacteria [45]. It is possible that our heterologous use of
these upjamA (-76 - 0) and upjamI (-67 - 0) regions in E.
coli could lead to false positive identification of promoters
in some instances. However, as previously discussed, the
organization of the gene cluster supports the utility of
functional promoters in both locations. The untranslated
leader region of jamA is long enough for the presence of
additional regulatory elements, and upjamI is a probable
location for a promoter because of the long jamI - M tran-
script. Further evaluation of these two possible promoters
will be necessary to determine how transcription from
their locations could affect subsequent protein transla-
tion.
Of particular interest in this study was the successful iso-
lation of proteins using "pulldown" experiments that
could be involved in the regulation of jamaicamide
expression. Gene clusters of marine cyanobacterial PKS/
NRPS secondary metabolites identified to date lack any
associated regulatory proteins that are imbedded in or in
proximity to the main cluster, in contrast to antibiotic
pathways in other prokaryotes such as actinobacteria [27].
This absence has led to the suggestion that secondary
metabolite pathways from L. majuscula could be constitu-
tively expressed [6]. By using the upstream region of jamA
as a DNA probe, we hoped to isolate putative regulatory
proteins from the soluble protein fraction of JHB. This
was predicted on the hypothesis that if the jamaicamide
pathway does have associated regulatory proteins, they
are located elsewhere in the genome. A biotinylated DNA
sequence from the jamaicamide pathway (1000 bp
upstream of jamA to 20 bp into the jamA gene) was incu-
bated with protein lysate from L. majuscula JHB. The
probe was long enough to encompass the entire untrans-
lated leader region of the pathway, as well as the primary
promoter and an additional 123 bp upstream of the pro-
moter -35 hexamer. Because transcription factors com-
monly bind at either the -35 box of the promoter itself, or
within 90 bp of the -35 box [46], it is probable that the
probe was long enough to capture proteins that might
associate with the promoter. The probe also allowed for
binding of regulatory proteins with affinity to the untrans-
lated leader region [37,47]. Analysis of protein samples
isolated from both an excised SDS-PAGE gel band andBMC Microbiology 2009, 9:247 http://www.biomedcentral.com/1471-2180/9/247
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elution fractions of several repeated pulldown assays con-
sistently identified two proteins in three separate data sets
using LC-MS/MS. These proteins were partially identified
using sequence data from the unfinished L. majuscula 3L
genome (unpublished), a strain from Curaçao responsi-
ble for the production of the anticancer compound
curacin A [5,48]. The two proteins (5335 and 7968) dis-
played strongest sequence identity to hypothetical pro-
teins found in other cyanobacteria, but could not
immediately be assigned a function. BLAST searches with
both proteins resulted in hits with RcaD, a protein
involved in complementary chromatic adaptation (CCA)
in another species of cyanobacteria [34]. Interestingly,
although the level of sequence identity of the two proteins
with RcaD was quite different (Table 2), both proteins (in
the 3L genome) had a similar gene neighborhood to
RcaD, indicating probable synteny. The L. majuscula 3L
proteins downstream of each (5336 and 7969) both had
BLAST hits with RcaG, the ATPase associated with RcaD,
although 7969 (49% identity) had significantly more
identity than 5336 (23% identity).
Complementary chromatic adaptation has been identi-
fied in a number of freshwater [36] and marine cyanobac-
teria [49]. In the cyanobacterial CCA model organism
Fremyella (= Calothrix, Tolypothrix), a photoreceptor circuit
involving the Rca receptors and response regulators
(RcaC, RcaE, RcaF, and RcaD) has been found to be
responsible for pigment modifications under red and
green light [35]. RcaD appears to affect several operons
during the acclimation phase of CCA [34]. Although Lyn-
gbya majuscula strains have not been observed to undergo
CCA in culture, there are several color morphotypes
known (for example, in our culture collection L. majuscula
3L is red under 16 h light/8 h dark cycles, while L. majus-
cula JHB is dark green). In addition, a microarray analysis
of cyanobacteria undergoing CCA found that over 80
genes were upregulated, including many not involved in
photosynthesis [50]. Considering the widespread effects
that CCA regulatory proteins play in cyanobacteria, it is
plausible that secondary metabolite production is regu-
lated by homologous proteins. Regulation by light could
also be in accordance with the mechanisms previously
described for the microcystin biosynthetic pathway
[21,22].
To further evaluate the two possible regulatory proteins
isolated in the pulldown assay, we overexpressed both
proteins in E. coli to evaluate their respective binding
affinities for the jamaicamide primary promoter region.
Protein 7968 was found to bind to the proposed transcrip-
tion factor binding region of the jamaicamide pathway
(1000-832 bp upstream of jamA; Figure 9a), and this DNA
binding activity was supported with serial protein titra-
tion (Figure 9b). Although we demonstrated that a con-
trol protein would not bind under the same conditions,
we also found that protein 7968 was able to bind nonspe-
cifically to several other unrelated pieces of DNA. Thus,
we were unable to assign a specific sequence for 7968
binding. Attempts to cleave the GST tag from the 5335
protein were unsuccessful, and binding assays indicated
that the GST+5335 fusion protein was not able to bind to
the same intergenic region as 7968 (Figure 9a; Additional
File 3: Figure S2). Because of its strong affinity with DNA,
7968 is the better candidate protein for providing tran-
scriptional regulation of the jamaicamide pathway. The
presence of multiple intergenic promoters in the pathway
could also offer other binding locations for additional reg-
ulation.
It is difficult to predict how the binding affinity of recom-
binant forms of 5335 or 7968 compares quantitatively
with the native proteins. Noubir et al. [34] found that
native RcaD bound much more effectively to the phycocy-
anin 2 promoter than a recombinant version, and hypoth-
esized that the reduced affinity may be from lack of
ATPase RcaG, which facilitates binding, or from lack of
phosphorylation. We attempted a dual-shift experiment
with 7968 and the GST tagged 5335, but no shift differ-
ences compared to 7968 alone were observed (data not
shown). It will be intriguing to determine whether 5335
and 7968 work in tandem to regulate the jamaicamide
pathway, or if they require downstream neighbors (5336
or 7969) to assist in binding. Alternatively, it is possible
that 7968 is the true regulator of the pathway, and 5335
was "pulled down" in the magnetic bead assay due to its
sequence identity being minimally sufficient for recogni-
tion. Interestingly, protein 7968 was found to form dim-
ers by PAGE analysis. Transcription factors often function
as dimers in their association with DNA and RNAP [46],
and thus, this finding also supports 7968 as the best can-
didate regulatory protein identified in this study.
If transcription factors are in fact regulating the expression
of secondary metabolites such as jamaicamide, it is useful
to consider the potential pleiotropic role of proteins such
as 7968 in regulating more than one biosynthetic pathway
in L. majuscula JHB. There are a number of similarities in
the secondary metabolite gene clusters of L. majuscula,
such as those encoding for the jamaicamides, hectochlo-
rin (also produced by the JHB strain; [39] and curacin A
[5,51]. For example, the genes jamA and hctA are both
ACP synthetases and are 58% identical, which might indi-
cate that similar regulatory proteins associate with the
upstream regions of each gene. If jamaicamide and hecto-
chlorin are both used in defense of L. majuscula against
predation or infection, their co-regulation would enhance
the defense of the strain. It is also interesting to speculate
that proteins in L. majuscula 3L homologous to jamaica-
mide regulatory proteins could be used to regulate pro-
duction of curacin A. A comparison of the approximately
1700 bp that separate jamA from its upstream neighbor-BMC Microbiology 2009, 9:247 http://www.biomedcentral.com/1471-2180/9/247
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ing gene (a transposase) with the upstream region of curA
from the curacin A pathway reveals that approximately
1550 bp of the upjamA region is 95% identical with the
upcurA  region. Moreover, proteins 5335 and 7968 are
99.6% and 89.5% identical with their respective
homologs in L. majuscula 3L (the curacin A producer). If
either of these two proteins functions as a pleiotropic reg-
ulator for natural products biosynthesis in L. majuscula,
their use in overexpression efforts would be valuable in
unlocking the full biosynthetic potential of these filamen-
tous marine cyanobacteria.
Ultimately, quantitative co-transcription analyses of the
two proteins with the rest of the jamaicamide pathway
and gene knockouts will be necessary to conclusively link
these proteins with jamaicamide regulation. Current
efforts are evaluating transcription levels of the two pro-
teins with both jamaicamide transcription and com-
pound production, and the effect of variable light
wavelengths on jamaicamide production in culture.
Because targeted gene manipulation techniques in L.
majuscula have not yet been developed, we are also in the
process of conducting methodology experiments to dis-
rupt or overexpress 5335 and 7968 to better understand
their functions, including their roles in global regulation.
Conclusion
Understanding the regulation of natural product path-
ways that encode compounds with pharmaceutical poten-
tial is important to overcoming the "supply issue" that is
so prevalent in natural products research [8]. While
marine cyanobacteria are recognized as prolific producers
of bioactive compounds, natural product yields from field
collections are low, and slow culture growth severely lim-
its the amount of compound that can be produced in this
manner. The transcriptional profile of the jamaicamide
biosynthetic gene cluster presented here provides insight
into the mechanisms by which these pathways are tran-
scribed and potentially regulated. Future advances in clas-
sifying promoters and transcription factors for
cyanobacterial gene clusters will be important to diverse
applications in biotechnology, such as combinatorial bio-
synthesis and the heterologous expression of entire natu-
ral product pathways. Additionally, this information
should also benefit ongoing efforts attempting to regulate
the expression of cyanobacterial toxins with deleterious
environmental impacts.
Methods
Bacterial strains, culture conditions, PCR reactions, and 
DNA measurements
Lyngbya majuscula JHB was originally collected from Hec-
tor's Bay, Jamaica [6] and was maintained in a culture
facility at Scripps Institution of Oceanography. Cultures
were grown in BG-11 saltwater media at 29°C under a
light intensity of approximately 5 μE m-2 s-1 and under 16
h light/8 h dark cycles. E. coli TOP-10 and BL-21 (DE3)
were grown in Luria-Bertani (LB) media. E. coli cultures
were grown with ampicillin (100 μg ml-1), or kanamycin
(50 μg ml-1) when necessary. PCR reactions were con-
ducted using either PCR Master Mix (Promega) or Pfx50
proofreading Taq Polymerase (Invitrogen). DNA concen-
trations were measured using either Beckman-Coulter
DU800 or NanoDrop 1000 (Thermo Scientific) spectro-
photometers. Protein concentrations for recombinant
JHB proteins were determined using the BCA assay
(Pierce). Ladders for DNA (Fermentas and New England
Biolabs) and protein (Bio-Rad) were used for size estima-
tions when necessary.
RT-PCR using L. majuscula RNA to search for the 
transcription start site (TSS) and promoter regions in the 
jamaicamide pathway
Cyanobacterial filaments (approximately 2 g wet weight)
from a culture of the jamaicamide producing strain of L.
majuscula JHB were harvested and subjected to RNA isola-
tion using TRIzol reagent (Invitrogen) and procedures
based on those recommended by the manufacturer with
minor modifications. RNA was treated with TURBO
DNAse (Ambion) for 2 h at 38°C before use in cDNA
reactions. To verify that genomic DNA contamination was
not present, in selected cases negative control reactions
were run in parallel with cDNA reactions in which reverse
transcriptase enzyme was omitted. For the primer exten-
sion experiment, first strand cDNA was synthesized from
the RNA using the primer upjamA 20-0 R (Sigma Genosys;
Additional file 1: Table S1) and the Superscript III Reverse
Transcriptase Protocol (Invitrogen) with minor modifica-
tions. Second strand reactions were conducted with prim-
ers ranging from 500-902 bp upstream in 50 bp
increments to determine where RNA transcription
upstream of jamA initiated. For cDNA synthesis of jamai-
camide intergenic regions, first strand cDNA was gener-
ated using either random (Invitrogen and [52]; Additional
file 1: Table S1) or specific jamaicamide upstream inter-
genic region reverse primers (Additional file 1: Table S1).
Forward and reverse oligonucleotide primers for each
upstream intergenic region of the cluster were used to PCR
amplify regions from the first strand cDNA to create sec-
ond strand cDNA. In some instances, sequencing was
used to confirm the correct amplification of second strand
cDNA, either by direct sequencing of PCR products or by
sequencing of TOPO TA cloning vectors (Invitrogen) con-
taining the intergenic region. All cDNA PCR products
were visualized on agarose gels.
Use of promoter prediction and  -galactosidase reporter 
gene assays to search for promoter activity
Each intergenic region upstream of the genes in the jamai-
camide pathway was examined for conserved binding
regions (in comparison to the σ70E. coli consensus pro-
moter) using the BPROM predictor (http://www.softBMC Microbiology 2009, 9:247 http://www.biomedcentral.com/1471-2180/9/247
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berry.com; Table 1). The upstream (up-) regions of genes
predicted to contain a promoter (jamA, jamB, jamC, jamD,
jamG, jamI, jamN, and jamQ) were amplified with specific
primers (Additional file 1: Table S1) from fosmids pro-
duced previously [6]. Each upstream section was individ-
ually cloned into the pBLUE TOPO vector (Invitrogen)
and transformed into TOP-10 E. coli. Plasmid purification
(Qiagen) and sequencing (Seqxcel, Inc., La Jolla, CA) were
used to confirm the sequence and direction of the inserts.
Verified clones were used to measure relative promoter
activity using the β-galactosidase reporter gene assay (Inv-
itrogen), standardized against total soluble protein con-
tent as measured by BCA assay (Pierce). For this protocol,
colonies from freshly streaked selective (100 μg ml-1 amp-
icillin) plates were grown overnight in LB media (5 ml).
Cultures were pelleted at 4000 RPM, and the pellets were
washed once with 3 ml of chilled PBS. After an additional
centrifugation step, the pellets were resuspended in 1 ml
PBS. The tube contents were centrifuged at 14,000 RPM
for 5 min, and subsequently resuspended in 110 μl lysis
buffer (0.25 mM Tris, pH 8.0). The cells were lysed by
freeze-thawing the suspensions 4 times with dry ice and a
37°C water bath, followed by another centrifugation
period. The supernatant was removed from each tube for
use in the β-galactosidase and BCA assays in a 96 well
plate. O-nitrophenol measurements from ONPG cleavage
in the assay were taken at 420 nm, while BCA readings
were taken at 570 nm (Thermo-Electron Multiskan Ascent
plate reader). Serial dilutions of lysis buffer from each cul-
ture were made to find an optimal range for colorimetric
detection of o-nitrophenol and for a comparison of rela-
tive activity (identified as a 3-fold dilution). Relative activ-
ity calculations were made by determining the average
nmol ONPG hydrolyzed min-1 mg soluble protein-1 value
for each vector insert and dividing each value by the high-
est overall average value to obtain a percentage. A frag-
ment of the pBAD TOPO vector (Invitrogen) containing
the arabinose promoter and vector ribosome binding site
(upstream of the TOPO cloning site) from E. coli was
found to consistently produce β-galactosidase in the
pBLUE TOPO vector in preliminary experiments, and was
used as a positive control. Because the arabinose operator
was not included in the positive control, the addition of
arabinose was not required to produce β-galactosidase. A
49 bp segment of the jamaicamide jamG gene was used as
a negative control. [Note: the pBLUE vector contains a
cryptic promoter that is reported to possibly limit the effi-
cacy of assaying other promoter fragments in a prokaryo-
tic host (Invitrogen). However, a series of preliminary
assays indicated significant and repeatable differences in
promoter activity between possible promoter regions, and
baseline activity in the negative control was sufficiently
low as to not conflict with the assay results. The BPROM
prediction software was used to verify that the vector con-
structs did not introduce any artificial promoters]. Those
regions found to have promoter activity were assayed
again with additional dilution (10 fold) to quantify pro-
moter strength, expressed as specific activity (nmol ONPG
hydrolyzed min-1 mg soluble protein-1).
Isolation of possible transcription factors from a pulldown 
assay
Protein pulldown experiments were based on methods
similar to [53]. A DNA probe that extended from 1000 bp
upstream of jamA to 20 bp into the jamA gene was ampli-
fied by PCR from the jamaicamide fosmid described
above using the primers upjamA  1000 biotin (bioti-
nylated at the 5' end; Invitrogen) and upjamA 20 - 0 R
(Additional file 1: Table S1). The PCR product was puri-
fied (MinElute PCR Purification Kit, Qiagen) and 10 pmol
of the biotinylated DNA were incubated with 1 mg of
magnetic M-270 streptavidin Dynabeads (Invitrogen),
according to the manufacturer's instructions. L. majuscula
JHB tissue was obtained from pan cultures that had been
growing for 1-2 months. Approximately 2-3 ml of culture
was measured by displacement in sterile, chilled binding
buffer [10 mM Tris-HCl (pH 7.5), 1 mM EDTA, 1 mM
DTT, 150 mM NaCl, and 5% (w/v) glycerol]. The binding
buffer was also treated with a broad range protease inhib-
itor (Complete, EDTA free; Roche). The tissue was soni-
cated and kept on ice using a probe sonicator with six 10-
s pulses, and insoluble material was pelleted at 13,200
RPM for 10 minutes. The soluble protein fraction (750 μl)
was added to each mg of DNA coated beads. One μg of
Poly DI-DC was also added to inhibit non-specific bind-
ing of protein to the DNA. Magnetic beads that were not
treated with biotinylated DNA were incubated with JHB
soluble protein as a negative control. The beads and solu-
ble protein were incubated for 1 h using an end-over-end
rotator at 4°C. The beads were subsequently washed twice
using 200 μl of binding buffer containing 100 μl sheared
salmon sperm DNA (Invitrogen; 5 mg ml-1), three times
with binding buffer, and eluted with 50 μl of binding
buffer containing 1.0 M NaCl. Wash fractions and elu-
tions were flash frozen in liquid N2 and concentrated on a
freeze dryer. After concentration, aliquots of each were
mixed with protein sample buffer, denatured for 3 min-
utes at 95-100°C, and analyzed by SDS-PAGE. The gels
were stained with either silver (Silverquest Kit, Invitrogen)
or colloidal Coomassie brilliant blue G-250.
Identification of DNA binding proteins
Once gel bands were visible in the elution fraction from
the binding assay, the assay was repeated on a larger scale
using additional replicates of the procedure described
above to isolate sufficient protein for mass spectrometry
(visible by colloidal Coomassie staining). Both gel bands
(excised using a scalpel) and whole elution fractions were
submitted to The Scripps Research Institute (La Jolla, CA)
Center for Mass Spectrometry for nano-LC MS/MS analy-
sis. Raw spectrum data (mzdata format) was obtained andBMC Microbiology 2009, 9:247 http://www.biomedcentral.com/1471-2180/9/247
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analyzed at UCSD by a DOS common-line version of
InsPecT 20070712 [31].
InsPecT search parameters for the mzdata files were the
following: (i) Lyngbya majuscula 3L common database
(unpublished data), common contaminants database,
reverse or "phony" database, and NCBI nr database; (ii)
parent ion Δm = 1.5 Da; (iii) b and y-ion Δm = 0.5 Da. Top
protein identifications were verified by using two different
database searches: (i) Lyngbya majuscula 3L genome alone;
(ii) NCBI nr with L. majuscula 3L genome inserted. The
mass spectral identifications of 5335 and 7968 were fur-
ther verified by manual annotation of the N-terminal and
C-terminal peptides, as well as the most abundant peptide
identified.
Characterization of putative transcription factors from a 
pulldown assay
Protein sequences detected using InsPecT were compared
with raw nucleotide sequences from the L. majuscula 3L
genome to identify their corresponding ORFs. Forward
and reverse primers (5335 F &R, 7968 F &R, Additional
file 1: Table S1) were designed from each sequence and
used to amplify the corresponding genes from L. majuscula
JHB. The blunt PCR products were cloned (Z-Blunt TOPO
vector, Invitrogen) and transformed into E. coli for
sequencing to compare the gene sequences from JHB with
those of 3L. Additional gene boundary primers (5335 FB,
5335 RB; 7968 FB, 7968 RB; Additional file 1: Table S1)
were used to amplify the JHB genes with priming sites 25
bp upstream and downstream in order to verify the
sequences covered by 5335 and 7968 forward and reverse
primers and avoid inclusion of sequences from L. majus-
cula  3L. Bioinformatic analyses of each gene sequence
were conducted using BLAST programs available through
the National Center for Biotechnology Information
(NCBI; http://blast.ncbi.nlm.nih.gov/).
Recombinant expression of identified proteins
Genes corresponding to identified proteins in the JHB
protein pulldown assay were amplified from JHB genomic
DNA using the primers 5335 Nco1F and 5335 Not1R or
7968 Nde1F and 7968 Xho1R (Additional file 1: Table
S1). Start codons in both gene sequences were changed
from either leucine (5335) or valine (7968) to methio-
nine for improvements in E. coli overexpression efforts.
PCR products from both reactions were purified and
digested with their corresponding restriction enzymes
(New England Biolabs). Gene 5335 was ligated into the
pGS21a vector (Genscript), which contains both an N-ter-
minal 6× His tag and GST tag. The 5335 construct was ver-
ified via transformation, plasmid isolation from TOP-10
E. coli, and sequencing. The vector containing the gene
sequence was then transformed into BL-21 (DE3) E. coli.
Four liters of E. coli harboring the 5335 pGS21a vector
were grown (using starter cultures) for 4 h at 37°C to an
OD600 between 0.6 and 1.0, induced with 0.7 mM IPTG,
and then grown at 18°C overnight. Cultures were centri-
fuged at 4500 RPM for 15 min at 4°C, and the ensuing
pellets from each liter of culture were resuspended in 5 ml
protein lysis buffer (20 mM Tris, pH 8.0, 500 mM NaCl,
and 20 mM imidazole) and lysed on ice using sonication
(6-7 10-s pulses). Resuspended lysate was centrifuged,
and supernatant containing soluble protein was incu-
bated on an end-over-end rotator at 4°C with Nickel-
Superflow resin (Qiagen) for 2 h. Following incubation,
the recombinant GST+5335  fusion protein was purified
using polypropylene columns (Qiagen). The nickel slurry
from the incubation was washed twice with protein wash
buffer (20 mM Tris, pH 8.0, 500 mM NaCl, and 50 mM
imidazole), and protein was eluted with 5 × 1 mL aliquots
of protein elution buffer (20 mM Tris, pH 8.0, 500 mM
NaCl, and 750 mM imidazole). Purified protein was dia-
lyzed against binding buffer (the same buffer used for the
pulldown assay, but not containing DTT) overnight using
a 50 kDa MWCO dialysis membrane (Spectrum Labs,
Rancho Dominguez, CA). To express 7968, the corre-
sponding gene sequence was ligated into the N-terminal
His tag containing pET28b vector (Novagen), and grown
and purified similarly to 5335 (although the 7968 wash
buffer contained 40 mM imidazole). Spectra/Por Float-A
Lyzer G2 dialysis membranes (20 kDa MWCO; Spectrum
Labs) were used to dialyze protein 7968. Concentrations
of each protein for use in assays were determined using
the BCA assay (Pierce).
Electromobility shift assays (EMSAs)
Gel shift EMSAs were performed to verify binding of 5335
and 7968 to jamaicamide promoter regions. The region
upstream of the jamaicamide TSS (1000 - 832 bp
upstream of jamA) was amplified from a jamaicamide fos-
mid using Pfx50 Taq Polymerase (Invitrogen). Each PCR
product was purified (MinElute kit, Qiagen) before being
used in the assay. For the comparative binding assay (Fig-
ure 9a), the N-terminal His tag was cleaved from protein
7968 using the Thrombin Cleavage Capture Kit (Nova-
gen). The cleaved 6× His tag was subsequently removed by
concentrating the protein sample over a Microcon 10,000
MWCO column (Millipore). SDS-PAGE gels and western
blotting were conducted to confirm the success of the
cleavage reaction. Serial titration of the 7968 protein to
verify DNA binding was performed using the recom-
binant version of the protein without His tag cleavage.
GST+5335 elutions were also concentrated over Microcon
10,000 MWCO columns prior to use in shift assays. For a
negative control, the purified recombinant protein
HctEIVA  from the hectochlorin pathway (purification
described in [39]) was used. The concentrations of HctEIVA
protein used in the EMSA experiments were measured
using a Bradford assay, and the purified HctEIVA included
a 6× N-terminal His tag from its expression vector
(pET28b; Novagen). Each gel shift assay reaction was per-BMC Microbiology 2009, 9:247 http://www.biomedcentral.com/1471-2180/9/247
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formed with the indicated quantities of DNA and purified
protein (Figure 9) in EMSA binding buffer adapted from
the DIG Gel Shift Kit, 2nd generation protocol (Roche) [20
mM HEPES, pH 7.6, 1 mM EDTA, 10 mM (NH4)2SO4, 1
mM DTT, Tween 20, 0.2% (w/v), 30 mM KCl] and water
(total volume 20 μl) for 30 min at room temperature. Fol-
lowing the incubation period, 5 μl of native loading dye
containing bromophenol blue was added to each reac-
tion, and the reaction contents were immediately trans-
ferred to a 10% native PAGE gel. The gels were
electrophoresed at 85 V for ~3.0 h in 0.5× TBE buffer (44.5
mM Tris, 44.5 mM boric acid, 1 mM EDTA), followed by
staining for at least 10 min in SYBR Gold Nucleic Acid Gel
Stain (Molecular Probes/Invitrogen) and visualization on
a UV transilluminator.
Sequence information
DNA and amino acid sequences of the proteins identified
in this study have been deposited in Genbank under the
accession numbers GQ860962 and GQ860963.
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